Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 6, 2010, Pages 561.e1-561.e5

  Foglia, Lisa M ^a   Ippolito, Danielle L ^b   Stallings, Jonathan D ^b   Zelig, Craig M ^a   Napolitano, Peter G ^a  

^a Department of Ob/Gyn   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Inflammation; Interleukin 6; Progesterone

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID;

ADULT; ARTICLE; ATTENUATION; BACILLUS SUBTILIS; CELL STIMULATION; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; EXTRACELLULAR SPACE; FEMALE; GESTATIONAL AGE; GRAM POSITIVE INFECTION; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MATERNAL BLOOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PREMEDICATION; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 85048646287     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.07.016     Document Type: Article

References (28)

1. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188: 419-24. (Pubitemid 36249980)
2. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alphahydroxyprogesterone caproate. N Engl J Med 2003;348: 2379-85. (Pubitemid 36682816)
3. O'Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30: 687-96. (Pubitemid 47612689)
4. American College of Obstetricians and Gynecologists. Use of progesterone to reduce preterm birth. ACOG committee opinion no. 419. Obstet Gynecol 2008;112: 963-5.
5. Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Maternal Fetal Neonatal Med 2006;19: 763-72. (Pubitemid 46039641)
6. Naccasha N, Gervasi MT, Chaiworapongsa T. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001;185: 1118-23. (Pubitemid 33097374)
7. Christianens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008;79: 50-7.
8. Haney AF, Weinberg JB. Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate. Am J Obstet Gynecol 1988;159: 450-4.
9. Davies S, Dai D, Wolf DM, Leslie KK. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. J Soc Gynecol Investig 2004;11: 494-9. (Pubitemid 39349203)
10. Bouman A, Moes H, Heineman MJ, de Leij LFMH, Faas MM. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril 2001;76: 555-9.
11. Amory J, Lawler R, Shields L. Hydroxyprogesterone caproate and progesterone increase tumor necrosis-alpha production in lipopolysaccharidestimulated whole blood from nonpregnant women. J Perinat Med 2005;33: 506-9. (Pubitemid 41769709)
12. Yuan M, Jordan F, McInnes IB, Harnett MM, Norman JE. Leukocytes are primed in peripheral blood for activation during labor. Mol Hum Reprod 2009;15: 713-24.
13. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179: 194-202. (Pubitemid 28394495)
14. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F. Inflammation in pregnancy. Reprod Sci 2009;16: 206-15.
15. Le Bouar G, Lassel L, Poulain P. Markers on infection and inflammation in the amniotic fluid: therapeutic contribution of amniocentesis. J Gynecol Obstet Biol Reprod 2002;31(Suppl 7): 5S52-6. (Pubitemid 35407958)
16. Splichal I, Trebichavsky I. Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol 2001;46: 345-51. (Pubitemid 33626713)
17. Romero R, Goncalves LF, Chaiworapongsa T, Kusanovic JP, Espinoza J. Mechanisms of preterm labor and preterm premature rupture of the membranes. In: Kurjak A, Chervenak FA, eds. Textbook of perinatal medicine, 2nd ed.London, UK: Informa UK Ltd; 2006: 1379-93.
18. Schwartz N, Xue X, Elovitz MA, Dowling O, Metz CN. Progesterone suppresses the fetal inflammatory response ex vivo. Am J Obstet Gynecol 2009;201: 211.e1-9.
19. Gotkin JL, Celver J, McNutt P, et al. Progesterone reduces LPS induced IL-6 secretion in fetoplacental chorionic arteries, fractionated cord blood and maternal mononuclear cells. Am J Obstet Gynecol 2006;195: 1015-9. (Pubitemid 44415676)
20. Katial RK, Sachanandani D, Pinney C, Lieberman MM. Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 1998;5: 78-81. (Pubitemid 28062951)
21. Jones LA, Anthony JP, Henriquez FL, et al. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 2008;125: 59-69.
22. Stopinska-Gluszak U, Waligora J, Grzela T, et al. Effect of estrogen/progesterone hormonereplacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 2006;69: 65-75. (Pubitemid 43144472)
23. Bouman A, Schipper M, Heineman MJ, Faas M. 17-beta-estradiol and progesterone do not influence the production of cytokines from lipopolysaccharide-stimulated monocytes in humans. Fertil Steril 2004;82(Suppl 3): 1212-9. (Pubitemid 39335941)
24. Duvigneau JC, Piskernik C, Haindl S, et al. A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of freeiron, and free iron mediated mitochondrial dysfunction. Lab Invest 2008;88: 70-7.
25. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired tolllikereceptor signaling. J Infect Dis 2007; 195: 296-302. (Pubitemid 46080062)
26. Kimbrell MR, Warshakoon H, Cromer JR, et al. Comparison of the immunostimulatory and proinflammatory activities of candidate Grampositive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol Lett 2008;118: 132-41.
27. Wang JE, Jorgensen PF, Almlof M, et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a humanwhole blood model. Infect Immun 2000; 3965-70. (Pubitemid 30434548)
28. Mattsson E, Hartung T, Morath S, Egesten A. Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan. Infect Immun 2004;4322-6. (Pubitemid 38821954)